+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bronchiectasis Pipeline Drugs and Companies, 2021- Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials

  • PDF Icon


  • 70 Pages
  • November 2021
  • Region: Global
  • VPA Research
  • ID: 5463886
Bronchiectasis pipeline drugs and companies, 2021- Phase, Mechanism of Action, Route, Licensing/collaboration, pre-clinical and clinical trials

The global comprehensive report on “Bronchiectasis pipeline drugs and companies” presents key-decision makers with critical insights into Bronchiectasis pipeline data. It provides complete analysis on pipeline drugs detailing Phases, route of administration, mechanism of action, licensing and collaborations, clinical trial details including pre-clinical phase and clinical trials.

Bronchiectasis pipeline Drug Snapshot, 2021

The Bronchiectasis pipeline study analyzes and monitors the development landscape with the current status of each of the pipeline drugs under development for Bronchiectasis. In addition to recent status, overview of drugs is included in the study. Wide range of Bronchiectasis drug related details including of company, indication, country, current status, drug alternative names, originator, orphan drug status, fast track details and others are provided.

Bronchiectasis drug development pipeline by phase

The Bronchiectasis pipeline study monitors the progress of new drug programs and provides analysis of phases, covering drugs from discovery to launch including discovery stage, preclinical, phase 1, phase 2, phase 3, pre-registration and other phases. The drug development stage for all Bronchiectasis pipeline candidates is provided in the report enables you to understand timetable developments in Bronchiectasis therapeutic area.

Bronchiectasis pipeline drug Technology, Licensing and Collaboration Details

Details of technologies used for development of Bronchiectasis pipeline candidates, licensing and collaboration agreements, partnership and other announcements, regulatory approval and other details are included in the Bronchiectasis research study. Companies looking to partner with other players are also detailed in the report.

Bronchiectasis- mechanism of action of pipeline candidates

Bronchiectasis pipeline guide details the mechanism of action of each of the drug candidate under development. Further, leading types of mechanism of action (MoA) targeted by different Bronchiectasis companies are identified to support decision makers target the most potential drugs under development.

Further, route of administration including oral, topical, sub-cutaneous, IV, ophthalmic and others are provided to assist researchers to understand most sought and least sought route of Bronchiectasis drug administration.

Bronchiectasis Drugs- Preclinical and Clinical Trials

This chapter in Bronchiectasis preclinical and clinical trials assists in gaining clear understanding of the timetable developments in Bronchiectasis product area. Preclinical and clinical trial details of pipeline candidates for Bronchiectasis are detailed in the report. Details including participants, duration, companies, locations and others are provided for the trials.

Bronchiectasis companies and Profiles

Companies developing Bronchiectasis pipeline products are analyzed in the industry report, presenting details of business overview, location, and year of establishment, contacts, key employees, and a brief business profile.

Bronchiectasis Market Developments

The report presents the recent news and developments in the Bronchiectasis pipeline industry. Progress of candidates, mergers, acquisitions, asset transactions, licensing, collaborations, partnership and joint ventures, regulatory approvals, marketing and other relevant news and deals are discussed in the report.

Reasons to Buy

  • Make better-informed decisions based on the current status of each of the pipeline drug candidate
  • Identify new business opportunities by evaluating the progress of the Bronchiectasis R&D pipeline
  • Analyze the market and research segments based on a comprehensive analysis of Bronchiectasis pipeline drugs and clinical trials
  • Identify Bronchiectasis drug pipeline trends based on consistently delivered hands on pipeline and clinical trials information
  • Gain clear understanding of the Bronchiectasis drugs through our expert coverage and in-depth analysis of drugs, companies and market trends
  • Check the Bronchiectasis pipeline progress of target companies and key strategies of leading players
  • Gain real-time insights into the global Bronchiectasis pipeline news, developments and insights

Scope of the Report

  • Disease overview including Bronchiectasis symptoms, widely used treatment options, companies and other details are included
  • Bronchiectasis Pipeline Summary including the dominant phase type, number of drug candidates progressing to advanced phases, early stage pipeline candidates, leading companies, dominant route of mechanism and route of administration and other details are provided.
  • Bronchiectasis pipeline drug count by phase, company and mechanism of action
  • Bronchiectasis companies investing R&D resources in pipeline
  • Dominant Mechanism of Action
  • Most researched route of administration
  • For each pipeline candidate, drug, originator, co-developers, other companies, special status, phase, synonym, current status and other details are included
  • Clinical trial information for each Bronchiectasis pipeline candidate are provided including preclinical, phase 1, phase 2 and phase 3 details
  • Bronchiectasis companies including their business snapshot, business description and Bronchiectasis pipelines are included.
  • Recent Bronchiectasis market developments, pipeline news and deals are provided

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Bronchiectasis Disease overview
2.2 Companies investing in Bronchiectasis industry
3 Bronchiectasis Pipeline Snapshot, 2021
3.1 Bronchiectasis Pipeline Drugs- Dominant phase type
3.2 Bronchiectasis pipeline Drugs- Leading Mechanism of Action
3.3 Bronchiectasis Pipeline Drugs- Widely researched Route of Administration
3.4 Bronchiectasis Pipeline- New Molecular Entity
3.5 Bronchiectasis pipeline- Companies, Universities and Institutes
4. Bronchiectasis Drug Profiles
4.1 Current Status of Bronchiectasis Drug Candidates, 2021
4.2 Bronchiectasis Drugs in Development- Originator/Licensor
4.3 Bronchiectasis Drugs in Development- Route of Administration
4.4 Bronchiectasis Drugs in Development- New Molecular Entity (NME)
5. Bronchiectasis Clinical Trials
5.1 Preclinical Trial details
5.2 Phase 1 Clinical Trial Details
5.3 Phase 2 Clinical Trial Details
5.4 Phase 3 Clinical Trial Details
6. Bronchiectasis Companies and Universities
6.1 Leading Bronchiectasis companies researching in drug development
6.2 Leading Bronchiectasis Universities/Institutes investing in drug development
7. Bronchiectasis News and Deals
7.1 Recent Bronchiectasis Market Developments
7.2 Pipeline Drug News Updates
7.3 Pipeline Company updates
8. Appendix
8.1 Sources and Research Methodology
8.2 Online Database
8.3 Primary and Secondary Methodology
8.4 Customization options
8.5 Contact